Atropine Solution/ Drops
FDA Label NDC 50090-7313

24 label sections · Submitted to the FDA by A-s Medication Solutions · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Atropine (NDC 50090-7313). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2 dosage and administration, 3 dosage forms and strengths, 4.1 hypersensitivity, 5.1 photophobia and blurred vision, 5.2 elevation of blood pressure, 5.3 risk of contamination, 6 adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.